Latest APGI News
PanKind foundation supports new study to improve immunotherapy outcomes in pancreatic cancer
The Avner Australian Pancreatic Cancer Matrix Atlas group (APMA) will investigate a potential new way to improve immunotherapy outcomes for patients with pancreatic cancer using a class of drug that can reduce the metabolic rewiring of the cancer cells thanks to a...
World Pancreatic Cancer Awareness Month
November is recognised as World Pancreatic Cancer Awareness Month. We take time to raise awareness of the disease, celebrate survivors and acknowledge pancreatic cancer research. Pancreatic cancer has now become the third leading cause of cancer deaths...
Pancreatic cancer ‘priming’ may make chemotherapy more effective
A new approach to ‘prime’ the tumour environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer. In preclinical models, a team at the Garvan Institute of Medical Research could...
Other News
Contact APGI
Australian Pancreatic Cancer Genome Initiative
The Kinghorn Cancer Centre
Garvan Institute of Medical Research
370 Victoria St, Darlinghurst
NSW 2010
Australia
On Twitter
